Copyright Reports & Markets. All rights reserved.

Global Cell-Based Multiplex Assays Market Growth (Status and Outlook) 2021-2026

Request for Sample of this report
Buy now

1 Scope of the Report

  • 1.1 Market Introduction
  • 1.2 Years Considered
  • 1.3 Research Objectives
  • 1.4 Market Research Methodology
  • 1.5 Research Process and Data Source
  • 1.6 Economic Indicators
  • 1.7 Currency Considered

2 Executive Summary

  • 2.1 World Market Overview
    • 2.1.1 Global Cell-Based Multiplex Assays Market Size 2016-2026
    • 2.1.2 Cell-Based Multiplex Assays Market Size CAGR by Region 2020 VS 2021 VS 2026
  • 2.2 Cell-Based Multiplex Assays Segment by Technology
    • 2.2.1 Flow Cytometry
    • 2.2.2 Flow Cytometry
    • 2.2.3 Multiplex Real-Time PCR
    • 2.2.4 Others
  • 2.3 Cell-Based Multiplex Assays Market Size by Technology
    • 2.3.1 Global Cell-Based Multiplex Assays Market Size CAGR by Technology
    • 2.3.2 Global Cell-Based Multiplex Assays Market Size Market Share by Technology (2016-2021)
  • 2.4 Cell-Based Multiplex Assays Segment by Application
    • 2.4.1 Pharmaceutical & Biotechnology Companies
    • 2.4.2 Hospitals & Research Institutes
    • 2.4.3 Others
  • 2.5 Cell-Based Multiplex Assays Market Size by Application
    • 2.5.1 Global Cell-Based Multiplex Assays Market Size CAGR by Application
    • 2.5.2 Global Cell-Based Multiplex Assays Market Size Market Share by Application (2016-2021)

3 Cell-Based Multiplex Assays Market Size by Players

  • 3.1 Cell-Based Multiplex Assays Market Size Market Share by Players
    • 3.1.1 Global Cell-Based Multiplex Assays Revenue by Players (2019-2021E)
    • 3.1.2 Global Cell-Based Multiplex Assays Revenue Market Share by Players (2019-2021E)
  • 3.2 Global Cell-Based Multiplex Assays Key Players Head office and Products Offered
  • 3.3 Market Concentration Rate Analysis
    • 3.3.1 Competition Landscape Analysis
    • 3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2019-2021E)
  • 3.4 New Products and Potential Entrants
  • 3.5 Mergers & Acquisitions, Expansion

4 Cell-Based Multiplex Assays by Regions

  • 4.1 Cell-Based Multiplex Assays Market Size by Regions (2016-2021)
  • 4.2 Americas Cell-Based Multiplex Assays Market Size Growth (2016-2021)
  • 4.3 APAC Cell-Based Multiplex Assays Market Size Growth (2016-2021)
  • 4.4 Europe Cell-Based Multiplex Assays Market Size Growth (2016-2021)
  • 4.5 Middle East & Africa Cell-Based Multiplex Assays Market Size Growth (2016-2021)

5 Americas

  • 5.1 Americas Cell-Based Multiplex Assays Market Size by Country (2016-2021)
  • 5.2 Americas Cell-Based Multiplex Assays Market Size by Technology (2016-2021)
  • 5.3 Americas Cell-Based Multiplex Assays Market Size by Application (2016-2021)
  • 5.4 United States
  • 5.5 Canada
  • 5.6 Mexico
  • 5.7 Brazil

6 APAC

  • 6.1 APAC Cell-Based Multiplex Assays Market Size by Region (2016-2021)
  • 6.2 APAC Cell-Based Multiplex Assays Market Size by Technology (2016-2021)
  • 6.3 APAC Cell-Based Multiplex Assays Market Size by Application (2016-2021)
  • 6.4 China
  • 6.5 Japan
  • 6.6 Korea
  • 6.7 Southeast Asia
  • 6.8 India
  • 6.9 Australia

7 Europe

  • 7.1 Europe Cell-Based Multiplex Assays by Country (2016-2021)
  • 7.2 Europe Cell-Based Multiplex Assays Market Size by Technology (2016-2021)
  • 7.3 Europe Cell-Based Multiplex Assays Market Size by Application (2016-2021)
  • 7.4 Germany
  • 7.5 France
  • 7.6 UK
  • 7.7 Italy
  • 7.8 Russia

8 Middle East & Africa

  • 8.1 Middle East & Africa Cell-Based Multiplex Assays by Region (2016-2021)
  • 8.2 Middle East & Africa Cell-Based Multiplex Assays Market Size by Technology (2016-2021)
  • 8.3 Middle East & Africa Cell-Based Multiplex Assays Market Size by Application (2016-2021)
  • 8.4 Egypt
  • 8.5 South Africa
  • 8.6 Israel
  • 8.7 Turkey
  • 8.8 GCC Countries

9 Market Drivers, Challenges and Trends

  • 9.1 Market Drivers and Impact
    • 9.1.1 Growing Demand from Key Regions
    • 9.1.2 Growing Demand from Key Applications and Potential Industries
  • 9.2 Market Challenges and Impact
  • 9.3 Market Trends

10 Global Cell-Based Multiplex Assays Market Forecast

  • 10.1 Global Cell-Based Multiplex Assays Forecast by Regions (2021-2026)
    • 10.1.1 Global Cell-Based Multiplex Assays Forecast by Regions (2021-2026)
    • 10.1.2 Americas Cell-Based Multiplex Assays Forecast
    • 10.1.3 APAC Cell-Based Multiplex Assays Forecast
    • 10.1.4 Europe Cell-Based Multiplex Assays Forecast
    • 10.1.5 Middle East & Africa Cell-Based Multiplex Assays Forecast
  • 10.2 Americas Cell-Based Multiplex Assays Forecast by Countries (2021-2026)
    • 10.2.1 United States Cell-Based Multiplex Assays Market Forecast
    • 10.2.2 Canada Cell-Based Multiplex Assays Market Forecast
    • 10.2.3 Mexico Cell-Based Multiplex Assays Market Forecast
    • 10.2.4 Brazil Cell-Based Multiplex Assays Market Forecast
  • 10.3 APAC Cell-Based Multiplex Assays Forecast by Region (2021-2026)
    • 10.3.1 China Cell-Based Multiplex Assays Market Forecast
    • 10.3.2 Japan Cell-Based Multiplex Assays Market Forecast
    • 10.3.3 Korea Cell-Based Multiplex Assays Market Forecast
    • 10.3.4 Southeast Asia Cell-Based Multiplex Assays Market Forecast
    • 10.3.5 India Cell-Based Multiplex Assays Market Forecast
    • 10.3.6 Australia Cell-Based Multiplex Assays Market Forecast
  • 10.4 Europe Cell-Based Multiplex Assays Forecast by Country (2021-2026)
    • 10.4.1 Germany Cell-Based Multiplex Assays Market Forecast
    • 10.4.2 France Cell-Based Multiplex Assays Market Forecast
    • 10.4.3 UK Cell-Based Multiplex Assays Market Forecast
    • 10.4.4 Italy Cell-Based Multiplex Assays Market Forecast
    • 10.4.5 Russia Cell-Based Multiplex Assays Market Forecast
  • 10.5 Middle East & Africa Cell-Based Multiplex Assays Forecast by Region (2021-2026)
    • 10.5.1 Egypt Cell-Based Multiplex Assays Market Forecast
    • 10.5.2 South Africa Cell-Based Multiplex Assays Market Forecast
    • 10.5.3 Israel Cell-Based Multiplex Assays Market Forecast
    • 10.5.4 Turkey Cell-Based Multiplex Assays Market Forecast
    • 10.5.5 GCC Countries Cell-Based Multiplex Assays Market Forecast
  • 10.6 Global Cell-Based Multiplex Assays Forecast by Technology (2021-2026)
  • 10.7 Global Cell-Based Multiplex Assays Forecast by Application (2021-2026)

11 Key Players Analysis

  • 11.1 Thermo Fisher Scientific
    • 11.1.1 Thermo Fisher Scientific Company Information
    • 11.1.2 Thermo Fisher Scientific Cell-Based Multiplex Assays Product Offered
    • 11.1.3 Thermo Fisher Scientific Cell-Based Multiplex Assays Revenue, Gross Margin and Market Share (2019-2021)
    • 11.1.4 Thermo Fisher Scientific Main Business Overview
    • 11.1.5 Thermo Fisher Scientific Latest Developments
  • 11.2 R&D Systems
    • 11.2.1 R&D Systems Company Information
    • 11.2.2 R&D Systems Cell-Based Multiplex Assays Product Offered
    • 11.2.3 R&D Systems Cell-Based Multiplex Assays Revenue, Gross Margin and Market Share (2019-2021)
    • 11.2.4 R&D Systems Main Business Overview
    • 11.2.5 R&D Systems Latest Developments
  • 11.3 Bio-Rad Laboratories
    • 11.3.1 Bio-Rad Laboratories Company Information
    • 11.3.2 Bio-Rad Laboratories Cell-Based Multiplex Assays Product Offered
    • 11.3.3 Bio-Rad Laboratories Cell-Based Multiplex Assays Revenue, Gross Margin and Market Share (2019-2021)
    • 11.3.4 Bio-Rad Laboratories Main Business Overview
    • 11.3.5 Bio-Rad Laboratories Latest Developments
  • 11.4 Protavio
    • 11.4.1 Protavio Company Information
    • 11.4.2 Protavio Cell-Based Multiplex Assays Product Offered
    • 11.4.3 Protavio Cell-Based Multiplex Assays Revenue, Gross Margin and Market Share (2019-2021)
    • 11.4.4 Protavio Main Business Overview
    • 11.4.5 Protavio Latest Developments
  • 11.5 Illumina
    • 11.5.1 Illumina Company Information
    • 11.5.2 Illumina Cell-Based Multiplex Assays Product Offered
    • 11.5.3 Illumina Cell-Based Multiplex Assays Revenue, Gross Margin and Market Share (2019-2021)
    • 11.5.4 Illumina Main Business Overview
    • 11.5.5 Illumina Latest Developments
  • 11.6 BD
    • 11.6.1 BD Company Information
    • 11.6.2 BD Cell-Based Multiplex Assays Product Offered
    • 11.6.3 BD Cell-Based Multiplex Assays Revenue, Gross Margin and Market Share (2019-2021)
    • 11.6.4 BD Main Business Overview
    • 11.6.5 BD Latest Developments
  • 11.7 Luminex Corporation
    • 11.7.1 Luminex Corporation Company Information
    • 11.7.2 Luminex Corporation Cell-Based Multiplex Assays Product Offered
    • 11.7.3 Luminex Corporation Cell-Based Multiplex Assays Revenue, Gross Margin and Market Share (2019-2021)
    • 11.7.4 Luminex Corporation Main Business Overview
    • 11.7.5 Luminex Corporation Latest Developments
  • 11.8 Agilent Technologies
    • 11.8.1 Agilent Technologies Company Information
    • 11.8.2 Agilent Technologies Cell-Based Multiplex Assays Product Offered
    • 11.8.3 Agilent Technologies Cell-Based Multiplex Assays Revenue, Gross Margin and Market Share (2019-2021)
    • 11.8.4 Agilent Technologies Main Business Overview
    • 11.8.5 Agilent Technologies Latest Developments
  • 11.9 Bio-Techne Corporation
    • 11.9.1 Bio-Techne Corporation Company Information
    • 11.9.2 Bio-Techne Corporation Cell-Based Multiplex Assays Product Offered
    • 11.9.3 Bio-Techne Corporation Cell-Based Multiplex Assays Revenue, Gross Margin and Market Share (2019-2021)
    • 11.9.4 Bio-Techne Corporation Main Business Overview
    • 11.9.5 Bio-Techne Corporation Latest Developments
  • 11.10 Shimadzu Biotech
    • 11.10.1 Shimadzu Biotech Company Information
    • 11.10.2 Shimadzu Biotech Cell-Based Multiplex Assays Product Offered
    • 11.10.3 Shimadzu Biotech Cell-Based Multiplex Assays Revenue, Gross Margin and Market Share (2019-2021)
    • 11.10.4 Shimadzu Biotech Main Business Overview
    • 11.10.5 Shimadzu Biotech Latest Developments

11. Abcam

  • 11.11.1 Abcam Company Information

According to this latest study, the 2021 growth of Cell-Based Multiplex Assays will have significant change from previous year. By the most conservative estimates of global Cell-Based Multiplex Assays market size (most likely outcome) will be a year-over-year revenue growth rate of % in 2021, from US$ million in 2020. Over the next five years the Cell-Based Multiplex Assays market will register a % CAGR in terms of revenue, the global market size will reach US$ million by 2026.

This report presents a comprehensive overview, market shares, and growth opportunities of Cell-Based Multiplex Assays market by product type, application, key players and key regions and countries.

Segmentation by technology: breakdown data from 2016 to 2021 in Section 2.3; and forecast to 2026 in section 10.7.
Flow Cytometry
Fluorescence Detection
Multiplex Real-Time PCR
Others

Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 10.8.
Pharmaceutical & Biotechnology Companies
Hospitals & Research Institutes
Others

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
Thermo Fisher Scientific
R&D Systems
Bio-Rad Laboratories
Protavio
Illumina
BD
Luminex Corporation
Agilent Technologies
Bio-Techne Corporation
Shimadzu Biotech
Abcam
Merck
Meso Scale Diagnostics
Promega Corporation
Siemens Healthineers
Boster Biological Technology
Buy now